Yahoo Web Search

Search results

    • At insurers convention, GLP-1s weigh heavy on conversations

      Crain s Chicago Business· 5 days ago

      The onus should be on providers — not insurers — to determine which patients may access glucagon-like peptide agnostics, or GLP-1s, Highmark Chief Medical Officer Dr. Timothy Law said at the ...